MyAverix Finance
F · Healthcare
AVACTA GROUP PLC LS-10 (RTQ1)
Biotechnology
AVACTA GROUP PLC LS-10 (RTQ1) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $339.17M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RTQ1
AVACTA GROUP PLC LS-10 (RTQ1) — FAQ
What is AVACTA GROUP PLC LS-10's market cap?
AVACTA GROUP PLC LS-10 (RTQ1) has a reported market cap of $339.17M (data as of 2026-03-30).
What is RTQ1's P/E ratio?
The price-to-earnings (P/E) ratio for AVACTA GROUP PLC LS-10 (RTQ1) is 18.00 (data as of 2026-03-30).
Does AVACTA GROUP PLC LS-10 pay a dividend?
Dividend yield is not available in the current snapshot for AVACTA GROUP PLC LS-10 (RTQ1). Check the MyAverix Finance app for the latest dividend data.
What sector is AVACTA GROUP PLC LS-10 in?
AVACTA GROUP PLC LS-10 (RTQ1) is classified in the Healthcare sector (Biotechnology industry).
What exchange is RTQ1 listed on?
RTQ1 is listed on F.
What is AVACTA GROUP PLC LS-10's net margin?
AVACTA GROUP PLC LS-10 (RTQ1) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.